Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
RSS SUMMARY · AGGREGATED FROM CNBC
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Micron and Qualcomm are among the most overbought stocks this week. Here are the others
CNBC·10h ago·3 min read
Health
MV Hondius hantavirus outbreak: A luxury expedition cruise boom and new world of remote travel risks
CNBC·10h ago·3 min read
Business
Why one of the nation’s largest auto lenders isn’t worried about high vehicle prices or ‘forever loans’
CNBC·11h ago·3 min read
US
U.S. sanctions companies and individuals in the Middle East and China for helping Iran
CNBC·12h ago·3 min read
Related
On this beat
Business
RBC revamps S&P 500 target for the rest of 2026
THE STREET·1h ago·3 min read
Business
Wedbush sends blunt message on Elon Musk’s Tesla and Intel deal
THE STREET·30m ago·3 min read
Business
Target’s genuine suede clog slippers are only $24
THE STREET·1h ago·3 min read
Business
Louis Navellier sends powerful message on AI FOMO trade, economy
THE STREET·2h ago·3 min read